Comparative, Randomized, Single-Dose, 2-way Crossover Bioavailability Study of Synerx Pharma and Verelan PM 300 mg Verapamil HCl Extended Release Capsules Controlled-Onset in Healthy Aduly Volunteers Under Fed Conditions
The purpose of this study is to determine the bioequivalency of Synerx Pharma Verapamil extended release capsules.
100 Clinical Results associated with Synerx Pharma LLC
0 Patents (Medical) associated with Synerx Pharma LLC
100 Deals associated with Synerx Pharma LLC
100 Translational Medicine associated with Synerx Pharma LLC